Overview

Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers

Status:
Unknown status

Trial end date:
2007-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether irbesartan will reduce the rate of recurrent atrial high rate episodes and the development of clinical sustained atrial fibrillation in patients with hypertension and permanent pacemaker.

Phase:

Phase 3

Details

Lead Sponsor:

Connolly, Stuart, M.D.

Collaborators:

Bristol-Myers Squibb
Sanofi

Treatments:

Irbesartan